Volume 1 - Issue 1 - Sept/Oct 2004

<sup>1</sup>Ruth L. Bush, MD and <sup>2</sup>Peter H. Lin, MD

Background Multiple sequellae may occur after deep venous thrombosis (DVT), including acute limb symptoms such as swelling and pain, valvular damage and reflux leading to chronic symptoms, and, the most serious, pulmonary embolism and death. Venous… | Read More

Frank J. Criado, Editor-in-Chief

It is with a sense of pride and excitement that I set out to write the first Editor’s Letter for the inaugural issue of Vascular Disease Management (VDM). This is a truly unique publication that was designed with the multi-disciplinary nature of… | Read More

Jacqueline Saw, MD, Jay S. Yadav, MD, Cameron Haery, MD, Derk W. Krieger, MD, Alex Abou-Chebl, MD

INTRODUCTION Intracranial angioplasty and stenting are increasingly being used to treat patients with recurrent cerebral ischemia due to intracranial atherosclerosis, which is a cause of 8-10% of all ischemic strokes. Since there are no commercially… | Read More

Nicolas W. Shammas, MS, MD, *Jon H. Lemke, PhD, Eric J. Dippel, MD, *Dawn E. McKinney, MA, Vickie S. Takes, RN, Monica Youngblut, RN, Melodee Harris, RN

This article is reprinted with permission from the Journal of Invasive Cardiology 2003;15:401-404. Unfractionated heparin (UFH) is the current antithrombotic agent utilized during peripheral angioplasty procedures (PTA). UFH has an unpredictable… | Read More

Nicolas W. Shammas, MS, MD

Percutaneous peripheral vascular procedures have increased exponentially over the past 10 years. Anderson et al.1 reported a 979% growth in peripheral vascular interventions since 1995, with a simultaneous drop in the number of surgical vascular… | Read More

Corey Goldman, MD, PhD

The patient is a 59-year-old hypertensive, diabetic, white male ex-smoker with a history of CABG in 1994. In 1997, he underwent insertion of a pacemaker for bradycardia. In 1999, he presented with hoarseness and was diagnosed with squamous cell… | Read More

David E. Allie

Critical limb ischemia (CLI) has only recently been characterized in the clinical literature; therefore knowledge of the clinical impact of CLI is still rudimentary at best. The TransAtlantic Inter-Societal Consensus (TASC) committee and document on… | Read More

An interview with Phillip Purdy, MD

What is PIN? PIN stands for percutaneous intraspinal navigation. Just as we’ve been using the arteries as a conduit to navigate the vascular system for a long time, we also believe it may be possible to use the space surrounding the brain and spinal… | Read More

<i>VDM</i> editorial board members share their thoughts

In our experience, the “when” occurred in the late 1990’s for the CLI subset of SFA/popliteal disease (in our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial) and the “when” began a year or so ago for… | Read More